Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
16 angezeigte Treffer · Seite 3, keine Gesamtzahl für „Padcev“
Suchtreffer
Begriffe & Kennungen
Padcev · 4.8 · Ocular disorders
Eintrag öffnenPadcev · 4.8 · Peripheral neuropathy
Eintrag öffnenPadcev · 4.8 · Reporting of suspected adverse reactions
Eintrag öffnenPadcev · 4.8 · Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows con
Eintrag öffnenPadcev · 4.8 · Skin reactions
Eintrag öffnenPadcev · 4.8 · Summary of the safety profile
Eintrag öffnenPadcev · 4.8 · Table 5. Adverse reactions in patients treated with enfortumab vedotin
Eintrag öffnenPadcev · 4.8 · The incidence of treatment-emergent anti-enfortumab vedotin antibody formation was consistent when assessed fo
Eintrag öffnenPadcev · 4.8 · The most common adverse reactions with enfortumab vedotin in combination with pembrolizumab were pruritus (44.
Eintrag öffnenPadcev · 4.8 · The most common adverse reactions with enfortumab vedotin were alopecia (47.7%), decreased appetite (47.2%), f
Eintrag öffnenPadcev · 4.8 · The most common serious adverse reactions (≥2%) were diarrhoea (2.1%) and hyperglycaemia (2.1%). Twenty-one pe
Eintrag öffnenPadcev · 4.8 · The most common serious adverse reactions (≥2%) were sepsis (3%), diarrhoea (2.6%), pneumonia (2.6%) and pneum
Eintrag öffnenPadcev · 4.8 · The safety of enfortumab vedotin was evaluated as monotherapy in 793 patients who received at least one dose o
Eintrag öffnenPadcev · 4.8 · The safety of enfortumab vedotin was evaluated in combination with pembrolizumab in 1 134 patients who receive
Eintrag öffnenPadcev · 4.8 · Thirty-eight percent of patients required a dose reduction due to an adverse reaction; the most common adverse
Eintrag öffnenPadcev · 4.8 · When enfortumab vedotin is administered in combination with pembrolizumab, refer to the SmPC for pembrolizumab
Eintrag öffnen